In the reported period, revenue for the company declined by 2% to R3.65 billion, and headline earnings per share saw a 50% decrease to 182.9 cents per share. Fund management earnings per share, a metric used to measure operating financial performance, dropped by 57% to 165.2 cents per share. Excluding the impact of the SARS matter, fund management earnings per share amounted to 370.2 cents per share, reflecting a 4% decrease from the prior corresponding period. The directors declared a final gross dividend of 165 cents per share.
Click here to read the SENS